Document Detail

Exercise-induced bronchoconstriction update: Therapeutic management.
MedLine Citation:
PMID:  22370529     Owner:  NLM     Status:  In-Data-Review    
Management of exercise-induced bronchoconstriction (EIB) should include both prevention and treatment directed toward the underlying asthma and bronchial hyperresponsiveness. Both nonpharmacologic and pharmacologic approaches should be followed. Preexercise warm-up, to take advantage of the refractory period that follows EIB, is an important preventive technique. Dietary interventions such as fish oil, vitamin D, and ascorbic acid have shown promising results. Beta 2-agonists are considered the most effective agents for EIB at this time but intermittent use is recommended to avoid tolerance or decreased effectiveness with daily regular use. Leukotriene inhibitors and mast cell stabilizing agents can be useful in EIB but are less effective than beta 2-agonists. Tolerance to beta 2-agonists is not prevented by concomitant use of inhaled corticosteroid but it is not known whether use of leukotriene inhibitors can affect tolerance. EIB in elite athletes with no underlying asthma may have a different pathogenesis.
Sheldon Spector; Ricardo Tan
Related Documents :
581679 - Electromyographic changes in postmeniscectomy patients. role of the pneumatic tourniquet.
9386249 - Vestibular rehabilitation strategies in meniere's disease.
20469229 - Physical exercise and post-coronary rehabilitation.
10538369 - Pc-based telerehabilitation system with force feedback.
11034729 - Exercise-based rehabilitation for coronary heart disease.
11328329 - Neurorehabilitation: a bridge between basic science and clinical practice.
6501039 - Pulmonary function changes after 1 h continuous heavy exercise in 0.21 ppm ozone.
3959859 - Special ergometric techniques and weight reduction.
7362549 - Serum cholesterol levels in selected air force cadets compared with levels in the west ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Allergy and asthma proceedings : the official journal of regional and state allergy societies     Volume:  33     ISSN:  1539-6304     ISO Abbreviation:  Allergy Asthma Proc     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-02-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9603640     Medline TA:  Allergy Asthma Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  7-12     Citation Subset:  IM    
1University of California, Los Angeles, Medical Center, Los Angeles, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A forced expiratory flow at 25-75% value <65% of predicted should be considered abnormal: A real-wor...
Next Document:  Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhi...